IBL International has entered a strategic collaboration with healthcare company Grifols to develop biomarker panels for ...

Shares in Spanish pharmaceutical company Grifols rose on Wednesday after Canadian fund Brookfield said it was talking with ...

IBL International GmbH, a Tecan company, which develops, manufactures and offers specialty diagnostics, today announced a ...

Brookfield had filed a non-binding offer on Nov. 19 for Grifols that valued the developer of human plasma-based drugs at ...

Canadian investment fund Brookfield (NYSE:BAM) resumed talks on a potential takeover of Spanish pharmaceuticals company ...

Under this collaboration, IBL will develop biomarker panels for specialty diagnostics based on Grifols’ random access, single ...

Canadian investment fund Brookfield (NYSE:BAM) resumed talks on a potential takeover of Spanish pharmaceuticals company Grifols ...

Shares in Grifols surged on Wednesday following a report that Canadian investment firm Brookfield had resumed takeover ...

Four investment groups with ties to the family that owns about 35% of Grifols SA confirmed they are in talks with Brookfield ...

Grifols and Brookfield said they aren't in takeover talks, after a media report indicated the investment company had resumed discussions with the Grifols family--which controls the Spanish ...

Canadian investment fund Brookfield has resumed talks on a potential takeover of Spanish pharmaceuticals company Grifols four ...

We recently published a list of 11 Best Russell 2000 Stocks to Buy According to Wall Street Analysts. In this article, we are ...